Table 6.
Changes in Crohn’s disease activity index scores according to subgroup (baseline to post treatment) (n = 85) (mean ± SD)
| Subgroup (treatment group/control group) | Treatment group | Control group | P value1 |
| Sex | |||
| Male (27/25) | -118.84 ± 47.29 | -48.97 ± 51.95 | 0.001 |
| Female (16/17) | -109.48 ± 67.45 | -16.14 ± 30.12 | 0.001 |
| CDAI at baseline | |||
| CDAI ≤ 220 (24/30) | -110.18 ± 49.51 | -26.87 ± 43.11 | 0.001 |
| CDAI > 220 (19/12) | -121.89 ± 62.10 | -57.70 ± 50.59 | 0.005 |
| Treatment with corticosteroids | |||
| Yes (11/13) | -131.30 ± 34.25 | -28.86 ± 32.35 | 0.001 |
| No (32/29) | -109.87 ± 60.05 | -38.73 ± 52.36 | 0.001 |
| Location | |||
| L1-Ileal (6/8) | -96.77 ± 55.42 | -19.70 ± 51.42 | 0.020 |
| L2-Colonic (8/11) | -114.31 ± 34.93 | -50.29 ± 46.47 | 0.005 |
| L3-Ileocolonic (29/23) | -119.49 ± 60.00 | -34.25 ± 45.56 | 0.001 |
1
P values from comparisons between treatment and control groups. CDAI: Crohn’s disease activity index.